Doebele Robert 4
4 · Boundless Bio, Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Doebele Robert
Chief Medical Officer
Transactions
- Award
Stock Option
2025-02-03+180,000→ 180,000 totalExercise: $2.23Exp: 2035-02-03→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option shall vest over a period of four years, with 25% of the shares subject to the option vesting on February 3, 2026, and the remaining shares subject to the option vesting in 36 equal monthly installments thereafter, subject to continued employment or service to the issuer on each such vesting date.